Vaxcyte Statistics Share Statistics Vaxcyte has 129.82M
shares outstanding. The number of shares has increased by 5.91%
in one year.
Shares Outstanding 129.82M Shares Change (YoY) 5.91% Shares Change (QoQ) 0.19% Owned by Institutions (%) 99.99% Shares Floating 125.45M Failed to Deliver (FTD) Shares 88 FTD / Avg. Volume 0.01%
Short Selling Information The latest short interest is 11.44M, so 8.81% of the outstanding
shares have been sold short.
Short Interest 11.44M Short % of Shares Out 8.81% Short % of Float 9.86% Short Ratio (days to cover) 7.37
Valuation Ratios The PE ratio is -21.53 and the forward
PE ratio is -5.55.
Vaxcyte's PEG ratio is
2.62.
PE Ratio -21.53 Forward PE -5.55 PS Ratio 0 Forward PS 228.6 PB Ratio 3.02 P/FCF Ratio -21.02 PEG Ratio 2.62
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Vaxcyte.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 12.75,
with a Debt / Equity ratio of 0.02.
Current Ratio 12.75 Quick Ratio 12.75 Debt / Equity 0.02 Debt / EBITDA -0.16 Debt / FCF -0.15 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.12M Employee Count 414 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -70.41% in the
last 52 weeks. The beta is 1.04, so Vaxcyte's
price volatility has been higher than the market average.
Beta 1.04 52-Week Price Change -70.41% 50-Day Moving Average 33.25 200-Day Moving Average 55.69 Relative Strength Index (RSI) 55.75 Average Volume (20 Days) 1,534,962
Income Statement
Revenue n/a Gross Profit n/a Operating Income -569.55M Net Income -463.93M EBITDA -448.08M EBIT -463.93M Earnings Per Share (EPS) -3.8
Full Income Statement Balance Sheet The company has 387.88M in cash and 71.11M in
debt, giving a net cash position of 316.77M.
Cash & Cash Equivalents 387.88M Total Debt 71.11M Net Cash 316.77M Retained Earnings -1.39B Total Assets 3.31B Working Capital 1.56B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -452.63M
and capital expenditures -22.43M, giving a free cash flow of -475.05M.
Operating Cash Flow -452.63M Capital Expenditures -22.43M Free Cash Flow -475.05M FCF Per Share -3.89
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
